Predicting mAb Subcutaneous Bioavailability from In Silico Structural Features
Time: 11:30 am
day: Day Two
Details:
- Assessing the current animal model gaps to test monoclonal antibody bioavailability
- Addressing the importance of understanding bioavailability for mAbs administered subcutaneously
- Leveraging in silico tools to predict bioavailability
